Searched for
PATIENT DATA SECURITY
Manipal Health leases Bengaluru hospital asset on nearly 30-year pactManipal Health Enterprises has secured a large hospital building in Bengaluru on a long-term lease. The deal spans almost 30 years, with a ...
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip raceElon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
Manipal Health picks up hospital building in Bengaluru through 30-year leaseManipal Health Enterprises has secured a large hospital building in Bengaluru's Yelahanka area. The lease spans nearly 30 years, with total...
Laid off by Oracle, Indian techie gets 3 new jobs in 45 days. He shares how he bagged the offers faster than expectedAfter getting laid off, a software engineer turned it into a major career comeback. He spent a focused 45 days diving deep into data struct...
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
Sir H.N. Reliance Foundation Hospital Claims Top Spot In Nationwide Critical Care SurveySir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
Lack of access to water, shelter at Delhi govt hospitals amid heatwave: ReportA recent audit highlights critical shortcomings in Delhi's heatwave relief for vulnerable populations. Homeless individuals and patient att...
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
'I walked out of my toxic job, and my boss told me to go back in for one last thing': A nursing home receptionist's story and the crisis behind itA receptionist at an assisted living facility resigned after being forced to manage residents with dementia attempting to leave, a task bey...
Dollar crashes against major currencies: Why is USD rate down today?U.S. dollar index fell about 0.3 per cent to 98.969. Euro rose 0.40 per cent to $1.1649 and the British pound gained 0.55 per cent to $1.35...
Cancer, Leo, Virgo Horoscope Today for May 25, 2026: Leadership Opportunities & Financial Stability AwaitYour Daily Horoscope Today emphasises financial growth, professional authority, and intellectual clarity. Favourable alignments foster stro...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...
Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answerThe gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath br...
Earnings are strong, but margin pain is coming; Dharmesh Kant on 3 sectors worth owning nowIndian corporate profits are currently strong. However, rising input costs present a significant challenge ahead. Investors should remain p...
Lord's Mark Industries Ltd. announces AI-supported Dialysis ecosystem launchLord's Mark Industries Ltd. has launched an integrated dialysis ecosystem in Ahmedabad, featuring the AI-driven Renalyx Machine. This CE-ce...